Product
belapectin
1 clinical trial
3 indications
Indication
Esophageal VaricesIndication
Nonalcoholic SteatohepatitisIndication
CirrhosisClinical trial
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH CirrhosisStatus: Active (not recruiting), Estimated PCD: 2024-12-01